Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA.
Department of Surgery, University of Rochester Medical Center, Rochester, NY 14642, USA.
Immunotherapy. 2021 Sep;13(13):1071-1078. doi: 10.2217/imt-2020-0329. Epub 2021 Jul 21.
Cytokine release syndrome (CRS) is an infrequently described immune-related adverse event of checkpoint inhibitors (CPI). CPI-induced CRS typically presents with fevers, hemodynamic instability and organ dysfunction within 2 weeks of the last treatment cycle. We report an unusual case of delayed and severe CRS occurring postoperatively in a patient with hepatic-limited metastatic colorectal cancer who received neoadjuvant immunotherapy. After a negative workup for alternative causes, he received prolonged corticosteroid treatment with symptom resolution. CPI-induced CRS can mimic sepsis and clinicians should maintain a high-index of suspicion to diagnose this immune-related adverse event early and initiate appropriate treatment. As use of perioperative immunotherapy increases, the potential role of surgery to trigger CRS in this case warrants further investigation.
细胞因子释放综合征(CRS)是一种罕见的免疫相关不良事件,发生于检查点抑制剂(CPI)治疗后。CPI 引起的 CRS 通常在最后一个治疗周期后 2 周内出现发热、血流动力学不稳定和器官功能障碍。我们报告了一例罕见的肝转移结直肠癌患者新辅助免疫治疗后延迟和严重 CRS 的病例。在排除其他原因后,他接受了长期皮质类固醇治疗,症状缓解。CPI 引起的 CRS 可模拟脓毒症,临床医生应保持高度警惕,早期诊断这种免疫相关不良事件,并进行适当的治疗。随着围手术期免疫治疗的应用增加,在这种情况下手术触发 CRS 的潜在作用值得进一步研究。
Am J Case Rep. 2024-4-16
Front Bioinform. 2025-1-17
Animal Model Exp Med. 2024-6
Am J Case Rep. 2024-4-16
Cancers (Basel). 2023-1-3
Infect Dis Clin North Am. 2022-12
Nat Rev Urol. 2020-2-4
Transl Lung Cancer Res. 2019-12
CA Cancer J Clin. 2020-1-16
BMC Infect Dis. 2019-9-11
Semin Cancer Biol. 2019-8-17
Immunol Rev. 2019-7
Case Rep Oncol. 2019-2-8
Clin Cancer Res. 2019-4-30